Company Information

Revenue, expenses and profitability over five years.

Income Statement

IND-SWIFT LABORATORIES LTD.

NSE Code: INDSWFTLABEQ
BSE Code: 532305
ISIN: INE915B01019
Industry: Pharmaceuticals

Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	635.89	549.65	1227.32	1151.96	988.09
Total Operating Revenues	635.89	549.65	1227.32	1151.96	988.09

Other Income	46.96	81.27	45.31	33.28	41.72
Total Revenue	682.84	630.92	1272.63	1185.24	1029.81

EXPENSES
Cost Of Materials Consumed	274.74	224.56	561.18	618.72	525.73
Purchase Of Stock-In Trade	37.66	70.80	25.33	10.46	1.06
Operating And Direct Expenses	0.00	50.32	100.68	111.28	84.08
Changes In Inventories Of FG,WIP And Stock-In Trade	-28.91	-10.36	37.07	-12.34	-39.47
Employee Benefit Expenses	136.33	115.33	148.88	132.70	111.88
Finance Costs	1.40	2.92	51.10	92.17	95.53
Depreciation And Amortisation Expenses	30.57	24.48	53.30	57.36	130.97
Other Expenses	169.83	111.93	104.20	69.05	110.34
Total Expenses	621.62	589.98	1081.75	1079.39	1020.12

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	61.22	40.94	190.88	105.85	9.69

Exceptional Items	-11.01	223.20	386.59	-26.65	-1.69
Profit/Loss Before Tax	50.22	264.14	577.47	79.20	8.00

Tax Expenses-Continued Operations
Current Tax	7.66	4.08	160.89	16.12	4.96
Less: MAT Credit Entitlement	0.00	-4.46	-8.98	2.98	-18.88
Deferred Tax	0.00	-3.83	-10.84	23.36	-10.92
Tax For Earlier Years	0.00	3.35	0.06	0.22	0.78
Total Tax Expenses	7.66	8.06	159.08	36.73	13.70
Profit/Loss After Tax And Before ExtraOrdinary Items	42.56	256.09	418.39	42.47	-5.71

Profit/Loss From Continuing Operations	42.56	256.09	418.39	42.47	-5.71

Profit/Loss For The Period	42.56	256.09	418.39	42.47	-5.71

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	5.09	38.08	70.81	7.19	-0.97
Diluted EPS (Rs.)	4.97	36.00	70.81	7.19	-0.97

Five-year consolidated Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	641.29	561.71	1280.90	1207.31	1038.73
Total Operating Revenues	641.29	561.71	1280.90	1207.31	1038.73

Other Income	46.97	81.38	45.37	33.50	42.71
Total Revenue	688.26	643.09	1326.27	1240.81	1081.45

EXPENSES
Cost Of Materials Consumed	271.74	224.20	599.06	657.46	565.00
Purchase Of Stock-In Trade	37.66	70.80	25.33	10.46	1.06
Operating And Direct Expenses	0.00	50.32	100.68	111.28	84.14
Changes In Inventories Of FG,WIP And Stock-In Trade	-26.94	-7.05	37.07	-12.34	-39.47
Employee Benefit Expenses	137.98	117.52	152.81	135.84	114.35
Finance Costs	1.40	2.92	51.10	92.17	95.53
Depreciation And Amortisation Expenses	30.61	24.48	53.30	57.36	131.04
Other Expenses	175.77	125.31	111.73	75.41	117.27
Total Expenses	628.21	608.50	1131.10	1127.64	1068.92

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	60.05	34.59	195.17	113.17	12.53

Exceptional Items	-11.01	223.20	386.59	-26.65	0.00
Profit/Loss Before Tax	49.05	257.80	581.76	86.52	12.53

Tax Expenses-Continued Operations
Current Tax	7.73	3.29	162.11	18.09	5.94
Less: MAT Credit Entitlement	0.00	-4.46	-8.98	2.98	-18.88
Deferred Tax	0.00	-3.82	-10.84	23.36	-10.92
Tax For Earlier Years	0.00	3.35	0.06	0.22	0.78
Total Tax Expenses	7.73	7.27	160.31	38.69	14.68
Profit/Loss After Tax And Before ExtraOrdinary Items	41.32	250.53	421.45	47.83	-2.15

Profit/Loss From Continuing Operations	41.32	250.53	421.45	47.83	-2.15

Profit/Loss For The Period	41.32	250.53	421.45	47.83	-2.15
Share Of Profit/Loss Of Associates	0.10	-0.05	-0.49	-0.23	0.00
Consolidated Profit/Loss After MI And Associates	41.42	250.48	420.96	47.60	-2.15

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	4.95	37.25	71.24	8.10	-0.36
Diluted EPS (Rs.)	4.84	35.21	71.24	8.10	-0.36

Source: Financial statements as reported by the company.